SCHEMBL19204855

SCHEMBL19204855

CCOC(=O)C(F)C(=O)CCOC

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
ALOX15 P16050 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
SOAT1 P35610 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
APEX1 P27695 1/20 0.31
CES2 O00748 1/20 0.31
CYP1A2 P05177 1/20 0.31
TRPA1 O75762 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3778175 0.82 CES2 (0.40) ALDH1A1ALOX15LMNAHSD17B10TSHR
SCHEMBL16465224 0.80 ALDH1A1 (0.37) ALDH1A1ALOX15LMNAHSD17B10MGAM
SCHEMBL3782518 0.77 SOAT1 (0.44) ALDH1A1ALOX15LMNAHSD17B10MGAM
SCHEMBL21004556 0.77 ALDH1A1 (0.35) ALDH1A1ALOX15TDP1LMNAHSD17B10
SCHEMBL223479 0.76 ALDH1A1 (0.50) ALDH1A1ALOX15LMNAHSD17B10TSHR
SCHEMBL125139 0.75 ALDH1A1 (0.40) ALDH1A1ALOX15LMNAHSD17B10MGAM
SCHEMBL27881486 0.74 ALDH1A1 (0.33) ALDH1A1ALOX15LMNAHSD17B10CYP3A4
SCHEMBL28081545 0.74 ALDH1A1 (0.39) ALDH1A1ALOX15LMNAHSD17B10MGAM
SCHEMBL16046285 0.70 TDP1 (0.37) ALDH1A1ALOX15TDP1CYP3A4TSHR
SCHEMBL30870369 0.70 ALDH1A1 (0.43) ALDH1A1ALOX15LMNAHSD17B10MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133670-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed